VRTX icon

Vertex Pharmaceuticals
VRTX

Overview Fund Activity

1,279 hedge funds and large institutions have $83.2B invested in Vertex Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 142 funds opening new positions, 484 increasing their positions, 484 reducing their positions, and 58 closing their positions.

Holders
1,279
Holders Change
+79
Holders Change %
+6.58%
% of All Funds
20.18%
Holding in Top 10
33
Holding in Top 10 Change
+9
Holding in Top 10 Change %
+37.5%
% of All Funds
0.52%
New
142
Increased
484
Reduced
484
Closed
58
Calls
$474M
Puts
$397M
Net Calls
+$76.5M
Net Calls Change
-$15.5M

Top Buyers

1
Capital Research Global Investors
1
Capital Research Global Investors
California
$1.08B
2
Capital World Investors
2
Capital World Investors
California
$6.1B
3
Millennium Management
3
Millennium Management
New York
$375M
4
Winslow Capital Management
4
Winslow Capital Management
Minnesota
$401M
5
Morgan Stanley
5
Morgan Stanley
New York
$979M

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$5.15B
2
Envestnet Asset Management
2
Envestnet Asset Management
Illinois
$108M
3
BlackRock
3
BlackRock
New York
$8.03B
4
AllianceBernstein
4
AllianceBernstein
Tennessee
$2.65B
5
Jennison Associates
5
Jennison Associates
New York
$1.34B
Name Market Value Shares Shares
Change 		Shares
Change %
BlackRock
1
BlackRock
New York
$8.03B 22,820,426 -1,086,177 -5%
Vanguard Group
2
Vanguard Group
Pennsylvania
$7.71B 21,895,959 +49,807 +0.2%
Capital World Investors
3
Capital World Investors
California
$6.1B 17,340,634 +1,196,211 +7%
Fidelity Investments
4
Fidelity Investments
Massachusetts
$5.15B 14,628,666 -1,647,189 -10%
State Street
5
State Street
Massachusetts
$4.34B 12,331,593 +124,141 +1%
Wellington Management Group
6
Wellington Management Group
Massachusetts
$2.66B 7,552,894 +35,346 +0.5%
AllianceBernstein
7
AllianceBernstein
Tennessee
$2.65B 7,535,034 -838,239 -10%
T. Rowe Price Associates
8
T. Rowe Price Associates
Maryland
$2.38B 6,758,758 +168,568 +3%
JPMorgan Chase & Co
9
JPMorgan Chase & Co
New York
$2.1B 5,955,525 -405,233 -6%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$1.95B 5,544,861 +135,604 +3%
Massachusetts Financial Services
11
Massachusetts Financial Services
Massachusetts
$1.39B 3,941,121 -103,910 -3%
Jennison Associates
12
Jennison Associates
New York
$1.34B 3,805,641 -774,160 -17%
Loomis, Sayles & Company
13
Loomis, Sayles & Company
Massachusetts
$1.15B 3,275,310 -96,336 -3%
ClearBridge Investments
14
ClearBridge Investments
New York
$1.11B 3,151,422 -186,319 -6%
Capital Research Global Investors
15
Capital Research Global Investors
California
$1.08B 3,061,676 +2,251,781 +278%
Ameriprise
16
Ameriprise
Minnesota
$1.06B 3,023,843 -366,017 -11%
Morgan Stanley
17
Morgan Stanley
New York
$979M 2,780,884 +427,823 +18%
Northern Trust
18
Northern Trust
Illinois
$944M 2,682,024 -94,671 -3%
Norges Bank
19
Norges Bank
Norway
$918M 2,608,911 +79,972 +3%
UBS AM
20
UBS AM
Illinois
$886M 2,811,731 – –
Bank of America
21
Bank of America
North Carolina
$823M 2,340,075 -245,069 -9%
Legal & General Group
22
Legal & General Group
United Kingdom
$749M 2,128,919 +42,588 +2%
Bank of New York Mellon
23
Bank of New York Mellon
New York
$703M 1,997,457 -40,447 -2%
Invesco
24
Invesco
Georgia
$686M 1,949,329 +87,961 +5%
Goldman Sachs
25
Goldman Sachs
New York
$639M 1,815,872 +104,141 +6%
1
2 3 4 5